Abstract
This study analyzed the secondary metabolite profile of Salicornia europaea inoculated with Brevibacterium casei EB3 and Pseudomonas oryzihabitans RL18 in aquaponic systems, exploring the metabolic mechanisms responsible for the observed shifts. Experiments were conducted in both microcosm and pilot-scale aquaponic setups to evaluate how these metabolic shifts vary across different system scales and their potential contributions to the observed increased accumulation of bioactive compounds with antioxidant and antimicrobial properties, including some phenolic acids, such as caffeic acid (154-fold), flavonoids (2.85-fold), and some unsaturated fatty acids, such as oct-3-enoic acid (32-fold). Metabolic profiling revealed shifts in pathways associated with plant growth and stress resilience, such as amino acid and phenolic biosynthesis. Additionally, differences in metabolic responses observed between microcosm and pilot-scale systems underscored the importance of understanding scaling effects. These findings highlight the potential for optimizing aquaponic systems by leveraging microbial-plant interactions to enhance ecological and economic outcomes. This approach offers valuable applications in nutrient recycling, phytopharmaceutical development, and the advancement of saline agriculture within integrated aquaculture frameworks.
Abstract from the paper’s OpenAlex record; open copy licensed cc-by. Read at the source ↗
The text the model read, with the source record’s inline markup (italics, sub- and superscripts) rendered and its character entities decoded; quote offsets refer to the raw text.
Claims 5
Claim · model-written summary
Inoculated Salicornia showed increased caffeic acid accumulation by 154-fold.
- Taxon
- Salicornia europaea
_01.jpg?width=60)
Salicornia europaeat0 - Treatment
- inoculated with Brevibacterium casei EB3 and Pseudomonas oryzihabitans RL18t1
- Interactor
- Brevibacterium casei EB3Brevibacterium caseit1symbiont
- Second interactor
- Pseudomonas oryzihabitans RL18Pseudomonas oryzihabitanst1symbiont
- Outcome
- caffeic acide0
- Direction
- increasede0
- Value
- 154-folde0
Not reportedComparator
Organisms pictured · Representative pictures of the matched species, not figures from the paper.
_01.jpg?width=500)
Verbatim
e0“increased accumulation of bioactive compounds with antioxidant and antimicrobial properties, including some phenolic acids, such as caffeic acid (154-fold), flavonoids (2.85-fold), and some unsaturated fatty acids, such as oct-3-enoic acid (32-fold).”
t0“Salicornia europaea”
t1“inoculated with Brevibacterium casei EB3 and Pseudomonas oryzihabitans RL18”
Claim · model-written summary
Inoculated Salicornia showed increased flavonoids accumulation by 2.85-fold.
- Taxon
- Salicornia europaeaSalicornia europaeat0
- Treatment
- inoculated with Brevibacterium casei EB3 and Pseudomonas oryzihabitans RL18t1
- Interactor
- Brevibacterium casei EB3Brevibacterium caseit1symbiont
- Second interactor
- Pseudomonas oryzihabitans RL18Pseudomonas oryzihabitanst1symbiont
- Outcome
- flavonoidse0
- Direction
- increasede0
- Value
- 2.85-folde0
Not reportedComparator
Organisms pictured · Representative pictures of the matched species, not figures from the paper.
Verbatim
e0“increased accumulation of bioactive compounds with antioxidant and antimicrobial properties, including some phenolic acids, such as caffeic acid (154-fold), flavonoids (2.85-fold), and some unsaturated fatty acids, such as oct-3-enoic acid (32-fold).”
t0“Salicornia europaea”
t1“inoculated with Brevibacterium casei EB3 and Pseudomonas oryzihabitans RL18”
Claim · model-written summary
Inoculated Salicornia showed increased oct-3-enoic acid accumulation by 32-fold.
- Taxon
- Salicornia europaeaSalicornia europaeat0
- Treatment
- inoculated with Brevibacterium casei EB3 and Pseudomonas oryzihabitans RL18t1
- Interactor
- Brevibacterium casei EB3Brevibacterium caseit1symbiont
- Second interactor
- Pseudomonas oryzihabitans RL18Pseudomonas oryzihabitanst1symbiont
- Outcome
- oct-3-enoic acide0
- Direction
- increasede0
- Value
- 32-folde0
Not reportedComparator
Organisms pictured · Representative pictures of the matched species, not figures from the paper.
Verbatim
e0“increased accumulation of bioactive compounds with antioxidant and antimicrobial properties, including some phenolic acids, such as caffeic acid (154-fold), flavonoids (2.85-fold), and some unsaturated fatty acids, such as oct-3-enoic acid (32-fold).”
t0“Salicornia europaea”
t1“inoculated with Brevibacterium casei EB3 and Pseudomonas oryzihabitans RL18”
Claim · model-written summary
Metabolic profiling found shifts in amino acid and phenolic biosynthesis pathways.
- Taxon
- Salicornia europaeaSalicornia europaeat0
- Outcome
- shifts in pathways associated with plant growth and stress resiliencee0
Organisms pictured · Representative pictures of the matched species, not figures from the paper.
Verbatim
e0“Metabolic profiling revealed shifts in pathways associated with plant growth and stress resilience, such as amino acid and phenolic biosynthesis.”
t0“Salicornia europaea”
t1“inoculated with Brevibacterium casei EB3 and Pseudomonas oryzihabitans RL18”
Claim · model-written summary
Metabolic responses differed between microcosm and pilot scale aquaponic systems.
- Taxon
- Salicornia europaeaSalicornia europaeat0
- Outcome
- differences in metabolic responsese0
- Setting
- microcosm and pilot-scale systemse0
Not reportedDirection
Organisms pictured · Representative pictures of the matched species, not figures from the paper.
Verbatim
e0“differences in metabolic responses observed between microcosm and pilot-scale systems underscored the importance of understanding scaling effects.”
t0“Salicornia europaea”
t1“inoculated with Brevibacterium casei EB3 and Pseudomonas oryzihabitans RL18”
The same questions in other papers
inoculation · molecular: metabolites · Salicornia europaea (common glasswort)Results agree
1 paper in the same direction as this paper
- positive
inoculation · quality: phytochemicals · Salicornia europaea (common glasswort)Results agree
1 paper in the same direction as this paper
- positive
Claims are grouped by organism, treatment and what was measured or targeted. A paper counts as positive when any of its claims in the group is positive.